Financials in USD. Standardized financial statements.
A compact view of how Syra Health Corp. Class A Common Stock turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue? | $7.23M | $7.98M | $5.52M | $5.62M | $1.41M | $0 |
| Revenue Growth? | -9.5% | +44.7% | -1.8% | +298.4% | 0.0% | 0.0% |
| Cost of Revenue? | $4.74M | $6.33M | $4.11M | $4.56M | $979,622 | $0 |
| Gross Profit? | $2.49M | $1.65M | $1.41M | $1.06M | $430,354 | $0 |
| Gross Margin? | +34.4% | +20.7% | +25.5% | +18.9% | +30.5% | 0.0% |
| Operating Expenses? | $3.39M | $5.42M | $4.30M | $3.15M | $433,634 | $4,267 |
| Operating Income? | -$904,324 | -$3.76M | -$2.89M | -$2.09M | -$3,280 | -$4,267 |
| EBITDA? | -$883,856 | -$3.68M | -$2.84M | -$2.07M | -$3,073 | -$4,267 |
| Income Before Tax | -$896,333 | -$3.76M | -$2.94M | -$2.12M | -$3,280 | -$4,267 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$896,333 | -$3.76M | -$2.94M | -$2.12M | -$3,280 | -$4,267 |
| EPS? | $-0.08 | $-0.52 | $-0.60 | $-0.36 | $-0.00 | $-0.00 |
| Diluted EPS? | $-0.08 | $-0.52 | $-0.60 | $-0.29 | $-0.00 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality